AD Knowledge Portal, ELITE Portal and Agora: Resources that empower the research community to find, access, and re‐use data and tools related to dementia and ageing

Abstract

Background: To identify disease‐modifying therapies and drug targets for Alzheimer's disease (AD), it is necessary to assess the impact of cellular and molecular dysfunction on disease aetiology. The AD Knowledge Portal (Portal) ( https://adknowledgeportal.org ), Exceptional Longevity Portal (ELITE) and Agora ( https://agora.

The paper